Company intelligence / Profile preview

SenesTech

Phoenix, Arizona, United Statessenestech.com ↗

Ownership: Public · SNES
Employees: ~33
Development stage: Commercial

Overview

SenesTech has developed and commercialized non-lethal rodent population management solutions based on fertility control. Its flagship product, ContraPest, has demonstrated over 90% reduction in rat populations when integrated into pest management programs. Evolve soft bait was launched as a next-generation product. Both have regulatory approval in the US; international expansion is underway with distribution agreements signed across several countries. No adverse effects on non-target species or food chains have been reported, supporting broad adoption across urban, agricultural, and sensitive environments such as zoos.

Modalities: Small moleculeDevice
Industry: Veterinary

Drug pipeline

2 assets

ContraPest

Commercial

Indications: Rat fertility control

1 more asset in the full pipeline.

Request access →

Partnerships

Evicom (distribution partner for Australia/New Zealand)

Financials

Market cap: $4.7M
Total revenue: $770K
Enterprise value: $2.2M

Beyond the preview

Go deeper on SenesTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SenesTech.

Explore the full profile